United States securities and exchange commission logo





                          February 17, 2023

       Brian Varnum, Ph.D.
       Chief Executive Officer
       Armata Pharmaceuticals, Inc.
       4503 Glencoe Avenue
       Marina del Rey, CA 90292

                                                        Re: Armata
Pharmaceuticals, Inc.
                                                            Registration
Statement on Form S-3
                                                            Filed February 13,
2023
                                                            File No. 333-269726

       Dear Brian Varnum:

              This is to advise you that we have not reviewed and will not
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Tyler
Howes at 202-551-3370 with any questions.




                          Sincerely,


                          Division of Corporation Finance

                          Office of Life Sciences
       cc:                                              Faith Charles, Esq.